JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB93560

PE Anti-MHC Class II (I-A/I-E) antibody [M5/114.15.2]

5

(1 Review)

|

(8 Publications)

Rat Monoclonal HLA-DPB1 antibody - conjugated to PE. Suitable for Flow Cyt and reacts with Mouse samples. Cited in 8 publications.

View Alternative Names

HLA-DP1B, HLA-DPB1, MHC class II antigen DPB1

1 Images
Flow Cytometry - PE Anti-MHC Class II (I-A/I-E) antibody [M5/114.15.2] (AB93560)
  • Flow Cyt

Supplier Data

Flow Cytometry - PE Anti-MHC Class II (I-A/I-E) antibody [M5/114.15.2] (AB93560)

Flow cytometry analysis showing C57Bl/6 splenocytes stained with ab93560 (solid line). The isotype control was Rat IgG2b PE (dashed line).

  • 660 APC

    APC Anti-MHC Class II (I-A/I-E) antibody [M5/114.15.2]

  • 519 FITC

    FITC Anti-MHC Class II (I-A/I-E) antibody [M5/114.15.2]

  • 450 violetFluor™ 450

    violetFluor™ 450 Anti-MHC Class II (I-A/I-E) antibody [M5/114.15.2]

  • violetFluor™ 500

    violetFluor™ 500 Anti-MHC Class II (I-A/I-E) antibody [M5/114.15.2]

Key facts

Host species

Rat

Clonality

Monoclonal

Clone number

M5/114.15.2

Isotype

IgG2b

Light chain type

kappa

Conjugation

PE

Excitation/Emission

Ex: 480;565nm, Em: 578nm

Carrier free

No

Reacts with

Mouse

Applications

Flow Cyt

applications

Specificity

The M5/114.15.2 monoclonal antibody reacts with the mouse major histocompatibility complex class II, both I-A and I-E subregion encoded glycoproteins (I-Ab, I-Ad, I-Aq, I-Ed, I-Ek, not I-Af, I-Ak, or I-As). It detects a polymorphic determinant present on B cells, monocytes, macrophages, dendritic cells, and activated T lymphocytes from mice carrying the H-2b, H-2d, H-2q, H-2p, H-2r and H-2u but not from mice carrying the H-2s or H-2f haplotypes. The M5/114 mnonclonal antibody is reported to inhibit I-A-restricted T cell responses of the H-2b, H-2d, H-2q, H-2u but not H-2f, H-2k, or H-2s haplotypes.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Mouse": { "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein G
Storage buffer
pH: 7.2 Preservative: 0.09% Sodium azide Constituents: 0.87% Sodium chloride, 0.16% Sodium phosphate, 0.1% Gelatin
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

MHC Class II also known as MHC II or human leukocyte antigen (HLA) class II is a protein complex with a molecular mass generally around 55 kDa. This protein is mainly expressed on the surface of antigen-presenting cells such as dendritic cells macrophages and B cells. It plays an important role in the immune system by presenting extracellular antigens to T helper cells. MHC II molecules are composed of two polypeptide chains alpha and beta which associate to form a heterodimer on the cell surface.
Biological function summary

MHC Class II molecules facilitate the immune system's recognition and response to pathogens by presenting processed antigenic peptides to CD4+ T lymphocytes. This activity involves their assembly within the endosomal-lysosomal system where they bind peptides derived from endocytosed proteins. MHC II is part of the major histocompatibility complex which includes other related molecules such as MHC Class I (HLA class I). The binding and presentation of peptides are central for the coordination of adaptive immune responses enhancing pathogen clearance and maintaining immunological memory.

Pathways

MHC Class II operates within the antigen processing and presentation pathway important for adaptive immunity. Its interaction with CD4+ T cells stimulates downstream signaling pathways leading to T cell activation and differentiation. Related proteins in the antigen presentation pathway include invariant chain (Ii) which guides MHC II to the endosome and HLA-DM which facilitates peptide loading. Together these proteins and pathways work to ensure effective immune surveillance and response.

Alterations in MHC Class II expression or function are associated with autoimmune diseases such as rheumatoid arthritis and type 1 diabetes. In these conditions improper antigen presentation may lead to an inappropriate immune response against self-proteins. The involvement of MHC II in disease is often linked to specific HLA alleles which vary among individuals and influence susceptibility to autoimmune disorders. Additionally the abnormal function of connected proteins like cytokines from activated T helper cells can exacerbate these immune conditions.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Binds peptides derived from antigens that access the endocytic route of antigen presenting cells (APC) and presents them on the cell surface for recognition by the CD4 T-cells. The peptide binding cleft accommodates peptides of 10-30 residues. The peptides presented by MHC class II molecules are generated mostly by degradation of proteins that access the endocytic route, where they are processed by lysosomal proteases and other hydrolases. Exogenous antigens that have been endocytosed by the APC are thus readily available for presentation via MHC II molecules, and for this reason this antigen presentation pathway is usually referred to as exogenous. As membrane proteins on their way to degradation in lysosomes as part of their normal turn-over are also contained in the endosomal/lysosomal compartments, exogenous antigens must compete with those derived from endogenous components. Autophagy is also a source of endogenous peptides, autophagosomes constitutively fuse with MHC class II loading compartments. In addition to APCs, other cells of the gastrointestinal tract, such as epithelial cells, express MHC class II molecules and CD74 and act as APCs, which is an unusual trait of the GI tract. To produce a MHC class II molecule that presents an antigen, three MHC class II molecules (heterodimers of an alpha and a beta chain) associate with a CD74 trimer in the ER to form a heterononamer. Soon after the entry of this complex into the endosomal/lysosomal system where antigen processing occurs, CD74 undergoes a sequential degradation by various proteases, including CTSS and CTSL, leaving a small fragment termed CLIP (class-II-associated invariant chain peptide). The removal of CLIP is facilitated by HLA-DM via direct binding to the alpha-beta-CLIP complex so that CLIP is released. HLA-DM stabilizes MHC class II molecules until primary high affinity antigenic peptides are bound. The MHC II molecule bound to a peptide is then transported to the cell membrane surface. In B-cells, the interaction between HLA-DM and MHC class II molecules is regulated by HLA-DO. Primary dendritic cells (DCs) also to express HLA-DO. Lysosomal microenvironment has been implicated in the regulation of antigen loading into MHC II molecules, increased acidification produces increased proteolysis and efficient peptide loading.
See full target information HLA-DPB1

Publications (8)

Recent publications for all applications. Explore the full list and refine your search

Theranostics 15:6022-6043 PubMed40365283

2025

pH-responsive nano-vaccine combined with anti-PD-1 antibodies for enhanced immunotherapy of breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Ning Wang,Hong Yu,Jianqiao Yin,Xiaopeng Yu

Immunology 163:98-104 PubMed33496963

2021

Skin antigen-presenting cells and wound healing: New knowledge gained and challenges encountered using mouse depletion models.

Applications

Unspecified application

Species

Unspecified reactive species

Aarthi Rajesh,Gabriella Stuart,Nicola Real,Allison Tschirley,Jenny Ahn,Lyn Wise,Merilyn Hibma

Immunology 160:366-381 PubMed32307696

2020

Depletion of langerin cells enhances cutaneous wound healing.

Applications

Unspecified application

Species

Unspecified reactive species

Aarthi Rajesh,Gabriella Stuart,Nicola Real,Jenny Ahn,Allison Tschirley,Lyn Wise,Merilyn Hibma

Infection and immunity 71:4137-43 PubMed12819105

2003

Bordetella bronchiseptica persists in the nasal cavities of mice and triggers early delivery of dendritic cells in the lymph nodes draining the lower and upper respiratory tract.

Applications

Unspecified application

Species

Unspecified reactive species

Pascale Gueirard,Patrick Ave,Anne-Marie Balazuc,Sabine Thiberge,Michel Huerre,Genevieve Milon,Nicole Guiso

International immunology 14:1179-91 PubMed12356683

2002

Cooperative interaction of Ig(alpha) and Ig(beta) of the BCR regulates the kinetics and specificity of antigen targeting.

Applications

Unspecified application

Species

Unspecified reactive species

Chang Li,Karyn Siemasko,Marcus R Clark,Wenxia Song

The American journal of pathology 160:141-9 PubMed11786408

2002

Induction and immunohistology of autoimmune ovarian disease in cynomolgus macaques (Macaca fascicularis).

Applications

Unspecified application

Species

Unspecified reactive species

Harini Bagavant,Colin Sharp,Barbara Kurth,Kenneth S K Tung

Journal of immunology (Baltimore, Md. : 1950) 128:1409-13 PubMed6173436

1982

A single monoclonal anti-Ia antibody inhibits antigen-specific T cell proliferation controlled by distinct Ir genes mapping in different H-2 I subregions.

Applications

Unspecified application

Species

Unspecified reactive species

R N Germain,A Bhattacharya,M E Dorf,T A Springer

Journal of immunology (Baltimore, Md. : 1950) 127:2488-95 PubMed6170707

1981

A shared alloantigenic determinant on Ia antigens encoded by the I-A and I-E subregions: evidence for I region gene duplication.

Applications

Unspecified application

Species

Unspecified reactive species

A Bhattacharya,M E Dorf,T A Springer
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com